Intravenous cangrelor vs oral ticagrelor in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous intervention: A randomised controlled trial

Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous intervention (PPCI). More potent P2Y12 inhibition improves clinical outcomes, however, oral agents have a slow